Dean B. Evans

7.1k total citations · 1 hit paper
107 papers, 5.6k citations indexed

About

Dean B. Evans is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Dean B. Evans has authored 107 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Genetics, 54 papers in Oncology and 45 papers in Molecular Biology. Recurrent topics in Dean B. Evans's work include Estrogen and related hormone effects (53 papers), Breast Cancer Treatment Studies (24 papers) and HER2/EGFR in Cancer Research (17 papers). Dean B. Evans is often cited by papers focused on Estrogen and related hormone effects (53 papers), Breast Cancer Treatment Studies (24 papers) and HER2/EGFR in Cancer Research (17 papers). Dean B. Evans collaborates with scholars based in Switzerland, United Kingdom and United States. Dean B. Evans's co-authors include William R. Miller, Matthew J. Ellis, F. Jänicke, Erhard Quebe‐Fehling, L. Mauriac, Andrew Coop, Mitch Dowsett, Margaret Dugan, Baljit Singh and A.S. Bhatnagar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Dean B. Evans

106 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

2001 790 citations Matthew J. Ellis, Andrew Coop et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dean B. Evans Switzerland	39	2.7k	2.1k	2.1k	2.0k	994	107	5.6k
Thierry Maudelondé France	41	2.2k 0.8×	2.2k 1.0×	1.0k 0.5×	1.9k 0.9×	551 0.6×	125	5.1k
Brigitte Bressac–de Paillerets France	43	3.5k 1.3×	3.7k 1.7×	1.5k 0.7×	2.1k 1.0×	785 0.8×	120	7.5k
Ronald J. Weigel United States	39	1.6k 0.6×	2.7k 1.3×	1.4k 0.7×	893 0.4×	690 0.7×	173	5.8k
Paul Haluska United States	38	2.0k 0.7×	2.5k 1.2×	667 0.3×	1.1k 0.6×	618 0.6×	114	4.9k
Yusuke Nakamura Japan	46	2.1k 0.8×	3.0k 1.4×	1.2k 0.5×	1.6k 0.8×	801 0.8×	134	6.6k
Mitsuru Emi Japan	45	1.4k 0.5×	3.1k 1.4×	1.4k 0.7×	1.1k 0.5×	888 0.9×	192	6.2k
Ryuichiro Doi Japan	48	4.4k 1.6×	2.9k 1.4×	580 0.3×	1.1k 0.6×	1.2k 1.2×	224	8.3k
Tom van Wezel Netherlands	42	2.1k 0.8×	2.4k 1.1×	910 0.4×	1.9k 0.9×	875 0.9×	188	5.7k
Giuseppe Viglietto Italy	48	2.3k 0.8×	5.4k 2.5×	663 0.3×	1.6k 0.8×	803 0.8×	150	8.2k
Edward A. Fox United States	33	1.7k 0.6×	4.8k 2.2×	1.8k 0.8×	1.2k 0.6×	709 0.7×	53	7.4k

Countries citing papers authored by Dean B. Evans

Since Specialization

Citations

This map shows the geographic impact of Dean B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean B. Evans more than expected).

Fields of papers citing papers by Dean B. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean B. Evans. The network helps show where Dean B. Evans may publish in the future.

Co-authorship network of co-authors of Dean B. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Dean B. Evans. A scholar is included among the top collaborators of Dean B. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean B. Evans. Dean B. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoshino, Osamu, Shirling Tsai, Mandana Kamgar, et al.. (2021). Arterial divestment (AD) versus arterial resection/reconstruction (AR) at the time of pancreatectomy for locally advanced pancreas cancer (LAPC). HPB. 23. S461–S461. 1 indexed citations

Tweats, David, George E. Johnson, Ivan Scandale, James Whitwell, & Dean B. Evans. (2015). Genotoxicity of flubendazole and its metabolitesin vitroand the impact of a new formulation onin vivoaneugenicity. Mutagenesis. 31(3). 309–321. 26 indexed citations

Bédard, Philippe L., Sandeep K. Singhal, Michail Ignatiadis, et al.. (2011). Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer. Endocrine Related Cancer. 18(6). 721–730. 6 indexed citations

Fowler, Paul, Richard A. Anderson, Philippa T. K. Saunders, et al.. (2011). Development of Steroid Signaling Pathways during Primordial Follicle Formation in the Human Fetal Ovary. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1754–1762. 88 indexed citations

Banerjee, Susana, Roger A’Hern, Simone Detre, et al.. (2010). Biological Evidence for Dual Antiangiogenic-Antiaromatase Activity of the VEGFR Inhibitor PTK787/ZK222584 In vivo. Clinical Cancer Research. 16(16). 4178–4187. 14 indexed citations

Miki, Yasuhiro, Takashi Suzuki, Keiko Abe, et al.. (2010). Intratumoral Localization of Aromatase and Interaction between Stromal and Parenchymal Cells in the Non–Small Cell Lung Carcinoma Microenvironment. Cancer Research. 70(16). 6659–6669. 51 indexed citations

Evans, Abigail, Sunil Pancholi, Ian Farmer, et al.. (2010). EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy. British Journal of Cancer. 102(8). 1235–1243. 18 indexed citations

Miller, William R., Alexey A. Larionov, Thomas Anderson, Dean B. Evans, & J. Michael Dixon. (2010). Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole. The Pharmacogenomics Journal. 12(1). 10–21. 35 indexed citations

Sato, Ryuichiro, Takashi Suzuki, Yu Katayose, et al.. (2009). Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors. Cancer Research. 69(3). 914–922. 56 indexed citations

10.

Das, Amrita, Srinivasa R. Mantena, Athilakshmi Kannan, et al.. (2009). De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis. Proceedings of the National Academy of Sciences. 106(30). 12542–12547. 108 indexed citations

11.

Banerjee, Susana, Marketa Zvelebil, Pascal Furet, et al.. (2009). The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase. Cancer Research. 69(11). 4716–4723. 21 indexed citations

12.

Ellis, Matthew J., Lin Li, Robert J. Crowder, et al.. (2009). Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. 119(2). 379–390. 110 indexed citations

13.

Lipton, Allan, Suhail M. Ali, Kim Leitzel, et al.. (2007). Elevated plasma tissue inhibitor of metalloproteinase‐1 level predicts decreased response and survival in metastatic breast cancer. Cancer. 109(10). 1933–1939. 40 indexed citations

14.

Dixon, J. Michael, Dana Faratian, Sharon White, et al.. (2007). DCIS and aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 173–179. 6 indexed citations

15.

Mackay, Alan, Ander Urruticoechea, J. Michael Dixon, et al.. (2007). Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Research. 9(3). R37–R37. 97 indexed citations

16.

Boulay, Anne, et al.. (2004). The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma. Cancer Research. 64. 1298–1298. 23 indexed citations

17.

Azria, D., Christel Larbouret, Séverine Cunat, et al.. (2004). Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Research. 7(1). R156–63. 58 indexed citations

18.

Ellis, Matthew J., Andrew Coop, Baljit Singh, et al.. (2003). Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.. PubMed. 63(19). 6523–31. 167 indexed citations

19.

Miller, William R., Thomas Anderson, Dean B. Evans, et al.. (2003). An integrated view of aromatase and its inhibition. The Journal of Steroid Biochemistry and Molecular Biology. 86(3-5). 413–421. 34 indexed citations

20.

Evans, Dean B., et al.. (1995). Letters to the editor [10]. Annals of Surgery. 221(1). 121–122. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact